Cloud Banner

Medical Devices

Image

Global Cartilage Regeneration Market – Industry Trends and Forecast to 2030

  • Medical Devices
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Cartilage Regeneration Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - 15.4% Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 984.25 Billion
Diagram Market Size (Forecast Year) USD 3095.64 Billion
Diagram CAGR 15.4%

Global Cartilage Regeneration Market, By Type (Fibro Cartilage, Hyaline Cartilage, Elastic Cartilage, Other), Treatment Modality (Cell-Based, Non-Cell Based), Treatment Type (Palliative, Intrinsic Repair Stimulus), Application Site (Knee, Spine, Ankle, Hip, Others), Surgical Procedure (Chondroplasty and Microfracture, Autologous Chondrocyte Implantation, Osteochondral Autograft Transplantation, Osteochondral Allograft Transplantation, Juvenile Allograft Fragments, Others), End User (Ambulatory Care Centers, Hospitals and Clinics, Surgical Centers, and Others) – Industry Trends and Forecast to 2030.

Cartilage Regeneration Market

Cartilage Regeneration Market Analysis and Size

According to the World Health Organization fact sheet on "Aging and Health," published in October 2021, the share of the population aged 60 and over was 1 billion in 2020 and is expected to increase to 1.4 billion by 2030, with 1 in 6 people worldwide expected to be aged 60 or over by 2030. This population was more likely to contract diseases and require cartilage repair/regeneration surgery. This growing geriatric population is expected to drive market growth. Furthermore, technological advancements and the development of novel treatment approaches are propelling the market forward. Currently, platelet-rich plasma injection, allografts, marrow stimulation drills, and extracellular matrix implants are being used to promote cartilage regeneration.

Data Bridge Market Research analyses that the cartilage regeneration market which was USD 984.25 million in 2022, is expected to reach USD 3095.64 million by 2030, at a CAGR of 15.4% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Cartilage Regeneration Market Scope and Segmentation  

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Fibro Cartilage, Hyaline Cartilage, Elastic Cartilage, Other), Treatment Modality (Cell-Based, Non-Cell Based), Treatment Type (Palliative, Intrinsic Repair Stimulus), Application Site (Knee, Spine, Ankle, Hip, Others), Surgical Procedure (Chondroplasty and Microfracture, Autologous Chondrocyte Implantation, Osteochondral Autograft Transplantation, Osteochondral Allograft Transplantation, Juvenile Allograft Fragments, Others), End User (Ambulatory Surgical Centers, Hospitals and Clinics, Surgical Centers, and Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe,  Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Osiris Therapeutics, Inc. (U.S.), Smith + Nephew (U.K.), AlloSource (U.S.), Vericel Corporation (U.S.), Zimmer Biomet (U.S.), Medtronic (Ireland), Stryker (U.S.), Anika Therapeutics, Inc. (U.S.), B. Braun SE (Germany), Orthocell Ltd. (Australia), Geistlich Pharma AG (Switzerland), Takeda Pharmaceutical Company Limited (Japan), CONMED Corporation (U.S.), The Future of Biotechnology, MEDIPOST (South Korea), BioTissue (U.S.), LifeNet Health (U.S.), RTI Surgical  (U.S.) and Arthrex, Inc. (Germany)

Market Opportunities

  • Rise in sports-related injuries

Market Definition

Cartilage regeneration is the process of stimulating damaged cartilage to heal itself. Cartilage has a low blood supply and no nerve endings, making it difficult for tissue damage to be repaired or healed naturally. The most common cause of cartilage degeneration is trauma or injury to the surface layer of articular (joint) cartilages in your knee, hip, shoulder, elbow, and other joints, which can lead to severe pain and inflammation as well as impaired joint movement.

Cartilage Regeneration Market Dynamics

Drivers

  • Growing number of road accidents

A growing number of road accidents worldwide are resulting in bone and joint injuries, which is expected to drive demand for cartilage repair products over the forecast period. For instance, according to data published by the World Health Organization (WHO) in November 2016, approximately 1.25 million people die each year in road accidents worldwide as a result of the influence of alcohol and reckless driving, the use of a mobile phone, and other associated factors such as bad weather and poor road construction. These are the certain factors which propel the market growth.

  • Increasing incidence of osteoarthritis

Osteoarthritis has become increasingly common in recent years throughout the world. According to a University of North Carolina study, approximately 1 million knee and hip replacement procedures are performed annually in the United States. The annual cost of osteoarthritis in the United States is $136.8 billion. According to the Arthritis Foundation, degenerative joint diseases such as osteoarthritis will affect more than 130 million people worldwide by 2050. Two of the most common treatments for osteoarthritis are autologous chondrocyte implantation and Scaffolds implants. As a result, as the prevalence of osteoarthritis rises, so the demand for cartilage regeneration also rises.

Opportunities

  • Rise in sports-related injuries

Sports-related injuries are on the rise in the United States, fuelling demand for products in the cartilage repair/regeneration market. According to a 2022 update from John Hopkins Medicine, more than 170,000 children aged 5 to 14 are treated in hospital emergency rooms in the United States for basketball-related injuries. Furthermore, the cartilage repair and regeneration market in North America is expanding due to more product launches, mergers, and acquisitions. For instance, in May 2021, the Arthritis Foundation of Georgia announced the launch of a new app (Vim, the Arthritis Foundation's mobile app) and kicked off Arthritis Awareness Month by releasing key findings from a patient study. As a result, this is expected to grow due to the factors mentioned above.

Restraints/Challenges

  • High cost of cartilage repair surgeries

Even though cartilage repair procedures produce better and longer-lasting results than total knee replacement surgeries, the cost of these treatments is one of the primary barriers to their use. On average, knee replacement treatments cost around USD 16,000, while cartilage repair procedures cost between USD 18,000 and USD 23,000, depending on where the procedure is performed. Due to their high cost, cartilage repair therapies are undervalued when compared to knee replacement surgeries, resulting in a lower preference for these procedures.

This cartilage regeneration market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cartilage regeneration market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In 2020, Smith & Nephew Plc launched Healicoil Knotless Suture Anchor. The unique combination of Healicoil Knotless Suture Anchor and Regenesorb Material is intended to stimulate a significant increase in the healing and bone fusion process.
  • In 2019, Cartistem, an allogeneic cell therapy product from Medipost Co. Ltd., began its phase 3 clinical trial to treat osteochondral cartilage defects in ankle joints.

Global Cartilage Regeneration Market Scope

The cartilage regeneration market is segmented on the basis of type, treatment modality, treatment type, application site, surgical procedure and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Fibro Cartilage
  • Hyaline Cartilage
  • Elastic Cartilage
  • Other

Treatment Modality

  • Cell-Based
  • Chondrocyte Transplantation
  • Growth Factor Technology
  • Non-Cell Based
  • Tissue Scaffolds
  • Cell-Free Composites

 Treatment Type

  • Palliative
  • Viscosupplementation
  • Debridement and Lavage
  • Intrinsic Repair Stimulus

 Application Site

  • Knee
  • Arthroscopic Chondroplasty
  • Autologous Chondrocyte
  • Osteochondral Grafts Transplantation
  • Cell-based Cartilage Resurfacing
  • Microfracture
  • Other
  • Spine
  • Ankle
  • Hip
  • Others

 Surgical Procedure

  • Chondroplasty
  • Microfracture
  • Autologous Chondrocyte Implantation
  • Osteochondral Autograft Transplantation
  • Osteochondral Allograft Transplantation
  • Juvenile Allograft Fragments
  • Others

 End User

Cartilage Regeneration Market Regional Analysis/Insights

The cartilage regeneration market is analyzed and market size insights and trends are provided by country, type, treatment modality, treatment type, application site, surgical procedure and end user as referenced above.

The countries covered in the cartilage regeneration market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the cartilage regeneration market because of the region's well-developed healthcare infrastructure and favourable reimbursement policies.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the increasing incidence of osteoporosis.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The cartilage regeneration market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for cartilage regeneration market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the cartilage regeneration market. The data is available for historic period 2011-2021.

Competitive Landscape and Cartilage Regeneration Market Share Analysis

The cartilage regeneration market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cartilage regeneration market.

Some of the major players operating in the cartilage regeneration market are:

  • Osiris Therapeutics, Inc. (U.S.)
  • Smith + Nephew (U.K.)
  • AlloSource (U.S.)
  • Vericel Corporation (U.S.)
  • Zimmer Biomet (U.S.)
  • Medtronic (Ireland)
  • Stryker (U.S.)
  • Anika Therapeutics, Inc. (U.S.)
  • B. Braun SE (Germany)
  • Orthocell Ltd. (Australia)
  • Geistlich Pharma AG (Switzerland)
  • Takeda Pharmaceutical Company Limited (Japan)
  • CONMED Corporation (U.S.)
  • The Future of Biotechnology, MEDIPOST (South Korea)
  • BioTissue (U.S.)
  • LifeNet Health (U.S.)
  • RTI Surgical (U.S.)
  • Arthrex, Inc. (Germany)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The cartilage regeneration market value was USD 984.25 million in 2022.
The cartilage regeneration market is projected to grow at a CAGR of 15.4% during the forecast period of 2023-2030.
The segments covered in the report are Type, Treatment Modality, Treatment Type, Application Site, Surgical Procedure, and End User
North America dominates the cartilage regeneration market because of the region's well-developed healthcare infrastructure and favourable reimbursement policies.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials